Imricor Medical Systems, Inc. Stock: price and insider trades · Australia
No insider purchase over the last 90 days. The latest, by Mr Aldo Denti Date of last notice 10 November 2025 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust, was filed 19 May 2026.
Imricor Medical Systems, Inc.: what insiders have been doing
Imricor Medical Systems, Inc., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to ASX. In the past year (27 October 2025 to 27 October 2026), 6 filings came from 6 insiders.
Every open-market trade in the period is a purchase: 5 purchases, from 5 insiders, and not a single sale. The totals exclude 5 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The buyers include 5 senior executives.
The last purchase on record was published on 19 May 2026, which is 172 days ago. Filings reach the ASX feed a median of 5 days after the trade. Until a filing is published, the market cannot know about the trade.
For context, the typical company on the same exchange (median of 1,602 companies) published 5 filings over the same period, against 6 filings here. Our records for Imricor Medical Systems, Inc. go back to 2026, with 5 purchases and no sales on the open market in total.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. Source: insider filings from ASX. Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- +13.2%Entry A$0.10 · Close at T+90 A$0.11
- +13.2%Entry A$0.10 · Close at T+90 A$0.11
- +13.2%Entry A$0.10 · Close at T+90 A$0.11
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Imricor Medical Systems, Inc. Strong Buy (bullish), based on 4 analysts. Average price target: A$2.97.
Financial data
as of FY 2025FY ended December 2025 · cache
- 23,007 sharesShareASXASX:2924-03091929-3A693650Canonical exit: 12 Aug 2026 (T+90)
- 28,317 sharesShareASXASX:2924-03091928-3A693649Canonical exit: 12 Aug 2026 (T+90)
- 26,547 sharesShareASXASX:2924-03091925-3A693648Canonical exit: 12 Aug 2026 (T+90)
- 33,626 sharesShareASXASX:2924-03091924-3A693647Canonical exit: 12 Aug 2026 (T+90)
- 422,719 sharesShareASXASX:2924-03091922-3A693646Canonical exit: 12 Aug 2026 (T+90)
- ShareASXASX:2924-03091646-3A693592
6 of 6 declarations
About Imricor Medical Systems, Inc.
IMR is a company listed on the XASX market. It operates in the financial sector.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
